Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job

被引：0
作者：
Melanie Schwerdtfeger
Mohamed-Reda Benmebarek
Stefan Endres
Marion Subklewe
Vincenzo Desiderio
Sebastian Kobold
机构：
[1] LMU Munich,Center of Integrated Protein Science Munich (CIPS
[2] University of Campania “Luigi Vanvitelli”,M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München
[3] German Center for Translational Cancer Research (DKTK),Department of Experimental Medicine
[4] German Research Center for Environmental Health (HMGU),Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München
[5] LMU Munich,Department of Medicine III, Klinikum der Universität München
来源：
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词：
Chimeric antigen receptor; Bispecific antibody; Immunotherapy; Adoptive T cell therapy; T cell redirection; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：218 / 233
页数：15
相关论文
共 50 条
[31]   Role of Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme [J].
Jindal, Vishal .
MOLECULAR NEUROBIOLOGY, 2018, 55 (11) :8236-8242
[32]   Chimeric Antigen Receptor T Cells in Myeloma [J].
Shimabukuro-Vornhagen, Alexander ;
Schloesser, Hans A. ;
von Bergwelt-Baildon, Michael S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (02) :193-194
[33]   Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today? [J].
Zhou, Xiang ;
Kortuem, K. Martin ;
Rasche, Leo ;
Einsele, Hermann .
PRESSE MEDICALE, 2025, 54 (01)
[34]   Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies [J].
Hoseini, Sayed Shahabuddin ;
Espinosa-Cotton, Madelyn ;
Guo, Hong-fen ;
Cheung, Nai-Kong, V .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[35]   Kinetics of Tumor Destruction by Chimeric Antigen Receptor-modified T Cells [J].
Anurathapan, Usanarat ;
Chan, Robert C. ;
Hindi, Hakeem F. ;
Mucharla, Roopa ;
Bajgain, Pradip ;
Hayes, Brendan C. ;
Fisher, William E. ;
Heslop, Helen E. ;
Rooney, Cliona M. ;
Brenner, Malcolm K. ;
Leen, Ann M. ;
Vera, Juan F. .
MOLECULAR THERAPY, 2014, 22 (03) :623-633
[36]   Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia [J].
Porter, David L. ;
Levine, Bruce L. ;
Kalos, Michael ;
Bagg, Adam ;
June, Carl H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :725-733
[37]   Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells [J].
Otahal, Pavel ;
Prukova, Dana ;
Kral, Vlastimil ;
Fabry, Milan ;
Vockova, Petra ;
Lateckova, Lucie ;
Trneny, Marek ;
Klener, Pavel .
ONCOIMMUNOLOGY, 2016, 5 (04)
[38]   Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins [J].
Debelec-Butuner, Bilge ;
Quitt, Oliver ;
Schreiber, Sophia ;
Momburg, Frank ;
Wisskirchen, Karin ;
Protzer, Ulrike .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[39]   Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies [J].
Cooper, Mathew L. ;
DiPersio, John F. .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
[40]   Galunisertib enhances chimeric antigen receptor-modified T cell function [J].
Wang, Zhixiong ;
Liu, Qian ;
Risu, Na ;
Fu, Jiayu ;
Zou, Yan ;
Tang, Jiaxing ;
Li, Long ;
Liu, Hui ;
Zhou, Guomin ;
Zhu, Xuekai .
EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2020, 64 :3-13
12345